This article is brought to you by the new Higher Learning LV Core Cannabis course. Learn the 25 most important cannabinoids and eight most common terpenes for an affordable enrollment fee of only $240.
Welcome to Cannabis Conclusions, a unique educational series from Higher Learning LV that is targeted at hemp and cannabis industry professionals. This series provides readers with the conclusion and abstract sections from important modern peer-reviewed research studies.
2023 Study: Cannabis for Orofacial Pain
2023 Study: Cannabis for Orofacial Pain. A May 2023 study entitled "Integrative Approach to the Therapeutic Use of Cannabis for Orofacial Pain" that was published in the journal SciELO—Scientific Electronic Library Online explored the potential efficacy of cannabis for pain—in particular, chronic pain.
The scientists explained that pain is defined as "an unpleasant perception associated with the activation of the nociceptive pathway." They reported that chronic pain, in particular, is more complex and lasts more than three months. The study noted that all types of pain are influenced by a number of factors, including "psychological, cognitive, behavioral, social, and neurophysiological factors."
"Scientists and medical professionals are seeking alternative treatments that may offer relief to chronic pain patients, including marijuana- and hemp-derived cannabinoids."
The study reported that particular types of chronic pain, including orofacial, are challenging to treat. "Chronic orofacial pain, including temporomandibular disorders (TMD) and neuropathic pain, as well as chronic pain in general, present difficult treatment management." Thus, scientists and medical professionals are seeking alternative treatments that may offer relief to chronic pain patients, including marijuana- and hemp-derived cannabinoids.
The study recommended a holistic methodology for treating chronic pain (what it called an "integrative approach") that has the goal of promoting "the health and well-being of the patient with a view that goes beyond the somatic causes." The research identified cannabinoids as one such "possible therapeutic option."
2023 Study: Cannabis for Orofacial Pain Conclusions
The scientists concluded that cannabinoids may present a viable treatment option for patients who suffer chronic pain, including the orofacial variety. The Conclusion section from this study appears below:
"Cannabinoids represent an important option for the control of chronic orofacial pain not only for their ability to reduce pain, but also to improve the quality of life of patients. Integrative treatment is undoubtedly the best way to go in the treatment of chronic pain in general, including orofacial pain.
"Cannabinoid therapy is part of this integrative approach and contributes to better therapeutic outcomes and improved quality of life for patients suffering from chronic orofacial pain."
"Cannabinoid therapy is part of this integrative approach and the combination of cannabinoids with other forms of activation of the endocannabinoid system contributes to better therapeutic outcomes and improved quality of life for countless patients suffering from chronic orofacial pain. Considering that cannabinoids are relatively safe compared to other drugs used to control chronic orofacial pain, they should be included in the arsenal of the TMD and orofacial pain specialist as an effective adjunct treatment."
View the original study.
Did you enjoy 2023 Study: Cannabis for Orofacial Pain? Are you a cannabis industry professional? Check out Higher Learning LV's Deep Dive Subscription that features dozens of long-form articles based on the latest peer-reviewed scientific research. Priced to accommodate personal and enterprise training budgets.